MFI and percentages of the metabolic enzyme PDH were significantly increased in CD11c+ cells of patients with NSCLC compared with healthy controls (Figure 7K and Supplemental Figure 7K). This evidence concerns the gene ITGAX and non-small cell lung carcinoma.